MedPath

The efficiency of Ramucirumab therapy for advanced gastric cancer after chemotherapy

Phase 4
Conditions
gastric cancer
Registration Number
JPRN-UMIN000021330
Lead Sponsor
Fujita Health University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

serious underlying disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath